eMedicine Specialties > Urology > Neurogenic Bladder and Overactive Bladder

Overactive Bladder in Children

Author: Pamela I Ellsworth, MD, FACS, Associate Professor of Urology, Brown University; Consulting Staff, University Urological Associates
Coauthor(s): Katherine M Callaghan, University of Massachusetts Medical School
Contributor Information and Disclosures

Updated: Feb 5, 2008

Introduction

Background

Idiopathic overactive bladder (OAB) is a term that has been adopted by the International Continence Society (ICS) to describe the symptom complex of urinary urgency, which may or may not be associated with urgency urinary incontinence, urinary frequency, and nocturia in the absence of pathologic or metabolic factors that cause or mimic these symptoms.1 In the pediatric literature, OAB is often referred to as -urge syndrome and is best characterized by frequent episodes of an urgent need to void, countered by contraction of the pelvic floor muscles and holding maneuvers such as squatting and the Vincent curtsy sign.

The cardinal symptom of OAB is urgency, which is defined as a sudden compelling desire to void that is often difficult to defer. Urgency must be differentiated from the urge to void, which is a normal sensation experienced by all individuals and may be intense when urine is held for a prolonged period. The definition of urinary frequency in a child is not well-established. However, many believe that a child who has a normal fluid intake and who voids more than 7 times per day has urinary frequency. The ICS defines nocturia as the need to wake at night one or more times to void.

Depending on fluid intake and urine production, children may experience more episodes of incontinence later in the day due to fatigue and an impaired ability to concentrate. In some cases, children with OAB remain dry during the day yet wet at night. However, such children experience daytime urgency and, often, daytime frequency.

Pathophysiology

The symptoms of OAB are believed to be caused by detrusor overactivity during the filling phase, causing urgency, as depicted in the image below. These detrusor contractions are countered by voluntary contraction of the pelvic floor muscles in an attempt to postpone voiding and to minimize wetting. The voiding phase is essentially normal but may be associated with a powerful detrusor contraction during voiding.
 

A urodynamic study demonstrating detrusor overact...

A urodynamic study demonstrating detrusor overactivity.

A urodynamic study demonstrating detrusor overact...

A urodynamic study demonstrating detrusor overactivity.


The natural history of OAB is not well-understood. Many believe that idiopathic OAB in children is the result of a maturation delay and that it resolves over time. This belief is in contrast to the theory behind OAB in adults, in whom the condition is believed to be chronic.

Frequency

United States

The prevalence of OAB in children is difficult to determine, as studies have focused primarily on daytime versus nighttime incontinence and have not attempted to differentiate the type of daytime incontinence. In a population survey of 1,192 individuals aged 1.5 to 27 years, diurnal accidents occurred in 13% of children aged 4 years, 7% of children aged 5 years, 10% of children aged 6 years, and 5% of children aged 7 years.2

International

Studies performed outside the United States have demonstrated that 2-4% of 7-year-old children have daytime or combined daytime and nighttime incontinence at least once per week and that it is more common in girls than in boys.3 In a population-based study of children aged 4-6 years in Australia, 19.2% had at least one daytime wetting episode in the preceding 6 months, with 16.5% having experienced more than one wetting episode and only 0.7% experiencing wetting on a daily basis.4 Up to 50.7% of children with daytime wetting have been noted to have urgency, with 79% wetting themselves at least once in a 10-day period.5

Mortality/Morbidity

Children with OAB have an increased risk of urinary tract infections (UTIs), which may be related to damage to the bladder mucosa during powerful detrusor contractions. In addition, frequent voluntary contractions of the pelvic floor muscles may also lead to postponement of defecation. Constipation and fecal soiling are often identified in children with OAB.

In addition, symptoms of pediatric OAB and urinary incontinence may lead to embarrassment in the child. The child may be inappropriately labeled as having a psychologic problem. Children with OAB may refrain from social activities, in fear of wetting and of letting others know how frequently they void. Difficulties may develop between the child and the child's peers, parents, or both.

Sex

Hellstrom et al (1990) assessed the prevalence of urinary incontinence in 7-year-old Swedish children.6 Diurnal incontinence was more common in girls (6.7%) than in boys (3.8%) . Wetting every week was reported in 3.1% of girls and in 2.1% of boys. Most children with diurnal incontinence had other symptoms. Urgency was reported in 4.7% of girls and in 1.3% of boys.

Age

Urge symptoms seem to peak in children aged 6-9 years and to diminish as they approach puberty, with an assumed spontaneous resolution rate for daytime wetting of 14% per year.7,8

Clinical

History

The clinical presentation of overactive bladder (OAB) in children is similar to that in adults. The clinical features include urgency, urinary frequency, urinary urge incontinence, and nocturia or nocturnal enuresis.

  • Children often exhibit various behaviors to prevent urinary leakage, including squatting behaviors and the Vincent curtsy sign.
  • Children may have a history of recurrent UTIs and constipation.
  • A careful voiding and bowel history, as well as a review of fluid intake (including type of fluid), is important to note.
  • In girls, voiding habits should be reviewed to ensure proper positioning during voiding to eliminate vaginal reflux voiding as a source of incontinence.

Physical

Physical examination findings are usually normal in children who have idiopathic OAB.

  • Children with urinary incontinence may have perineal excoriation.
  • A focused neurologic examination should be performed to rule out an underlying neurologic etiology. The examination includes an assessment of perineal sensation, assessment of the perineal reflexes supplied by sacral segments S1-S4 (standing on toes, bulbocavernosus reflex), evaluation of anal sphincter tone, and evaluation of the buttocks, legs, and feet for signs of occult neurospinal dysraphisms of the lumbosacral area.
  • The position and caliber of the urethral meatus should be inspected.
  • The abdominal examination should include assessment for a distended bladder and a full sigmoid/descending colon suggestive of constipation.
  • The sacrum should be palpated to ensure that it is present and the presacral area inspected for dimples, abnormal gluteal clefts, hairy patches, and other signs of possible neurologic lesions.

Causes

In children, OAB may arise from various etiologies, including neurogenic, anatomic, inflammatory, and idiopathic causes. Neurogenic etiologies include myelomeningocele, cerebral palsy, spinal cord injury, sacral agenesis, and imperforate anus. Twenty-two percent of children with a lumbosacral myelomeningocele have uninhibited bladder contractions.9 In children with cerebral palsy, an unstable bladder is the most common urologic anomaly.

The most common anatomic abnormality associated with OAB is posterior urethral valves; 24% of males with this condition have OAB.10 Inflammatory processes in the bladder wall (eg, UTIs) may irritate receptors in the submucosa and detrusor muscle layers and may lead to OAB symptoms. Idiopathic OAB is thought to be secondary to delayed maturation of the reticulospinal pathways and inhibitory centers in the midbrain and cerebral cortex.

More on Overactive Bladder in Children

Overview: Overactive Bladder in Children
Differential Diagnoses & Workup: Overactive Bladder in Children
Treatment & Medication: Overactive Bladder in Children
Follow-up: Overactive Bladder in Children
Multimedia: Overactive Bladder in Children
References
Further Reading

References

  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-78. [Medline].

  2. Bloom DA, Seeley WW, Ritchey ML, McGuire EJ. Toilet habits and continence in children: an opportunity sampling in search of normal parameters. J Urol. May 1993;149(5):1087-90. [Medline].

  3. Kuh D, Cardozo L, Hardy R. Urinary incontinence in middle aged women: childhood enuresis and other lifetime risk factors in a British prospective cohort. J Epidemiol Community Health. Aug 1999;53(8):453-8. [Medline].

  4. Sureshkumar P, Craig JC, Roy LP, Knight JF. Daytime urinary incontinence in primary school children: a population-based survey. J Pediatr. Dec 2000;137(6):814-8. [Medline].

  5. Järvelin MR, Vikeväinen-Tervonen L, Moilanen I, Huttunen NP. Enuresis in seven-year-old children. Acta Paediatr Scand. Jan 1988;77(1):148-53. [Medline].

  6. Hellstrom AL, Hanson E, Hansson S, Hjalmas K, Jodal U. Micturition habits and incontinence in 7-year-old Swedish school entrants. Eur J Pediatr. Mar 1990;149(6):434-7. [Medline].

  7. Forsythe WI, Redmond A. Enuresis and spontaneous cure rate. Study of 1129 enuretis. Arch Dis Child. Apr 1974;49(4):259-63. [Medline].

  8. Himsl KK, Hurwitz RS. Pediatric urinary incontinence. Urol Clin North Am. May 1991;18(2):283-93. [Medline].

  9. Dator DP, Hatchett L, Dyro FM, Shefner JM, Bauer SB. Urodynamic dysfunction in walking myelodysplastic children. J Urol. Aug 1992;148(2 Pt 1):362-5. [Medline].

  10. Peters CA, Bolkier M, Bauer SB, Hendren WH, Colodny AH, Mandell J, et al. The urodynamic consequences of posterior urethral valves. J Urol. Jul 1990;144(1):122-6. [Medline].

  11. Lettgen B, von Gontard A, Olbing H, Heiken-Lowenau C, Gaebel E, Schmitz I. Urge incontinence and voiding postponement in children: somatic and psychosocial factors. Acta Paediatr. 2002;91(9):978-84; discussion 895-6. [Medline].

  12. van Gool JD, de Jonge GA. Urge syndrome and urge incontinence. Arch Dis Child. Nov 1989;64(11):1629-34. [Medline].

  13. Kuo HC. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology. Mar 2003;61(3):550-4. [Medline].

  14. Hohenfellner M, Dahms SE, Matzel K, Thüroff JW. Sacral neuromodulation for treatment of lower urinary tract dysfunction. BJU Int. May 2000;85 Suppl 3:10-9; discussion 22-3. [Medline].

  15. Klingler HC, Pycha A, Schmidbauer J, Marberger M. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology. Nov 1 2000;56(5):766-71. [Medline].

  16. Sureshkumar P, Bower W, Craig JC, Knight JF. Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials. J Urol. Jul 2003;170(1):196-200; discussion 200. [Medline].

  17. Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology. Mar 2002;59(3):428-32. [Medline].

  18. Palmer LS, Zebold K, Firlit CF, Kaplan WE. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol. Feb 1997;157(2):638-40. [Medline].

  19. Ferrara P, D'Aleo CM, Tarquini E, Salvatore S, Salvaggio E. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int. May 2001;87(7):674-8. [Medline].

  20. Hjälmås K, Hellström AL, Mogren K, Läckgren G, Stenberg A. The overactive bladder in children: a potential future indication for tolterodine. BJU Int. Apr 2001;87(6):569-74. [Medline].

  21. Lopez Pereira P, Miguelez C, Caffarati J, Estornell F, Anguera A. Trospium chloride for the treatment of detrusor instability in children. J Urol. Nov 2003;170(5):1978-81. [Medline].

  22. Kjølseth D, Madsen B, Knudsen LM, Nørgaard JP, Djurhuus JC. Biofeedback treatment of children and adults with idiopathic detrusor instability. Scand J Urol Nephrol. Sep 1994;28(3):243-7. [Medline].

  23. Curran MJ, Kaefer M, Peters C, Logigian E, Bauer SB. The overactive bladder in childhood: long-term results with conservative management. J Urol. Feb 2000;163(2):574-7. [Medline].

  24. Cvitkovic-Kuzmic A, Brkljacic B, Ivankovic D, Grga A. Ultrasound assessment of detrusor muscle thickness in children with non-neuropathic bladder/sphincter dysfunction. Eur Urol. Feb 2002;41(2):214-8; discussion 218-9. [Medline].

  25. Franco I. Overactive bladder in children. Part 1: Pathophysiology. J Urol. Sep 2007;178(3 Pt 1):761-8; discussion 768. [Medline].

  26. Franco I. Overactive bladder in children. Part 2: Management. J Urol. Sep 2007;178(3 Pt 1):769-74; discussion 774. [Medline].

  27. Müller L, Bergström T, Hellström M, Svensson E, Jacobsson B. Standardized ultrasound method for assessing detrusor muscle thickness in children. J Urol. Jul 2000;164(1):134-8. [Medline].

Further Reading

For additional information, see Medscape’s Urinary Incontinence & OAB Resource Center.

Keywords

overactive bladder, pediatric overactive bladder, overactive bladder in children, idiopathic overactive bladder, idiopathic OAB, urge syndrome, unstable bladder, detrusor overactivity, detrusor overactivity of a neurogenic etiology, neurogenic detrusor overactivity, OAB, dysfunctional voiding, voiding postponement, urinary urgency, urgency urinary incontinence, urinary frequency, nocturia, Vincent curtsy sign, Vincent’s curtsy, Vincent curtsey, Vincent’s curtsey, pelvic floor muscles, cerebral palsy, spinal cord injury, sacral agenesis, imperforate anus, posterior urethral valves, neuromodulation, urinary tract infection, UTI, bladder augmentation, bladder autoaugmentation, oxybutynin, Ditropan XL

Contributor Information and Disclosures

Author

Pamela I Ellsworth, MD, FACS, Associate Professor of Urology, Brown University; Consulting Staff, University Urological Associates
Pamela I Ellsworth, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Surgeons, American Urological Association, Phi Beta Kappa, Society for Fetal Urology, and Society of University Urologists
Disclosure: Pfizer Consulting fee Consulting; Novartis Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Allergan Honoraria Speaking and teaching

Coauthor(s)

Katherine M Callaghan, University of Massachusetts Medical School
Disclosure: Nothing to disclose.

Medical Editor

Gamal Mostafa Ghoniem, MD, FACS, Fellowship Program Director, Clinical Professor of Surgery, Head, Section of Voiding Dysfunction, Female Urology and Reconstruction, Cleveland Clinic Florida
Gamal Mostafa Ghoniem, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urogynecologic Society, American Urological Association, Florida Medical Association, International Continence Society, and International Urogynaecology Association
Disclosure: Astellas Honoraria Speaking and teaching; Coloplasty Consulting fee Consulting; Uroplasty Consulting fee Consulting

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

CME Editor

J Stuart Wolf Jr, MD, FACS, David A Bloom Professor of Urology, Director of Division of Minimally Invasive Urology, Department of Urology, University of Michigan
J Stuart Wolf Jr, MD, FACS is a member of the following medical societies: American College of Surgeons, American Urological Association, Catholic Medical Association, Endourological Society, Society for Urology and Engineering, Society of Laparoendoscopic Surgeons, Society of University Urologists, and Society of Urologic Oncology
Disclosure: Terumo Corporation Consulting fee Consulting; Gyrus-ACMI Honoraria Speaking and teaching

Chief Editor

Edward David Kim, MD, FACS, Professor of Surgery, Division of Urology, University of Tennessee Graduate School of Medicine; Consulting Staff, University of Tennessee Medical Center
Edward David Kim, MD, FACS is a member of the following medical societies: American College of Surgeons, American Society for Reproductive Medicine, American Society of Andrology, American Urological Association, and Tennessee Medical Association
Disclosure: Lilly Consulting fee Consulting; Astellas Consulting fee Speaking and teaching; Indevus Consulting fee Speaking and teaching

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.